Land: Australië
Taal: Engels
Bron: Department of Health (Therapeutic Goods Administration)
bleomycin sulfate, Quantity: 15000 IU
Hospira Australia Pty Ltd
bleomycin sulfate
Injection, powder for
Excipient Ingredients:
Intraarterial, Intramuscular, Intraperitoneal, Intravenous, Subcutaneous, Intralesional, Intrapleural
10 x 10 mL vials, 1 x 10 mL vial
Medicine Listed (Export Only)
Not scheduled. Not considered by committee
Squamous cell carcinoma affecting the mouth, nasopharynx, larynx, paranasal sinuses, oesophagus, external genitalia, cervix or skin. Hodgkin's disease and other malignant lymphomas including mycosis fungoides. Testicular teratoma. Malignant effusions of the serous cavities. Metastatic melanoma and the carcinomas of the thyroid, lung and bladder.
Visual Identification: A white to cream coloured lyophilised powder or plug; Container Type: Vial; Container Life Time: 2 Years
Licence status A
2006-02-15